Kristof Capelle34:52
Thank you, Linda. Good afternoon everybody, and also from my side it's really an honor and a pleasure to present to you our company, Gimv. You will see that it is already a proof of the variety that you can invest in if you invest in listed private capital, because Gimv is an example of another approach with regards to value creation in private equity, but I will elaborate more on that in the course of my presentation. As it is said on this slide, we are a specialized European mid-market investment company. We are a direct investor in growth companies, and we are an investment company, not a fund. So there is already the big difference in the sense that for more than 40 years now we are investing directly in companies with money that is provided to us by our shareholders who buy the listed stock. So if you buy a stock of Gimv, you buy in fact access to a portfolio of growth companies that is directly on our balance sheet. We do that with a solid balance sheet, we have sufficient liquidity and equity strength in order to continue to invest and to continue our growth. With the business model that we have and also the funding model that we have, we can have the flexibility to have a long-term view on value creation because we don't feel the urge of limited partners that might be eager to get their cash back. We can be more flexible in that respect. We do have a way of sharing the returns we make with our shareholders, but I will come back to that later on as well. A quick overview of what we are in terms of figures. We have today a portfolio on our balance sheet of 1.2 billion euros. In total we manage 2 billion euros, so a large chunk of that is already invested in our portfolio. The portfolio consists of 57 portfolio companies, so you see that the average ticket is about 20 million euros, that is what we on average invest, but we have a very wide range there. We invest tickets with 5 to 75 million euros in one individual company. These 57 portfolio companies in total generate 2.8 billion euros and employ 15,000 professionals within them. In these companies, as I said, we exist for more than 40 years because we have started our activities in 1980, and we are listed on the Brussels Stock Exchange as of 1997, so now for 24 years already. Over the time we have generated a net return for the shareholders on an annual basis of 11.5%. We are an investment company with offices in four countries: Belgium, the Netherlands, Germany, and France. So we look to the low to mid-market private equity activities in these four countries. But we are not organized according to a geographical scope, but we are organized according to what we call investment platforms, and we see this on the next slide where you see the four investment platforms, let's say the four areas of
Specialization with which we look at potential growth companies to be added to our portfolio. These four areas are consumer, health and care, smart industries, and sustainable cities. So the composition of our investment teams is according to these four platforms and not according to the countries where we have our own offices. So for instance, an investment manager of the health and care team in Paris will have more exchange with his health and care colleague in the Hague in the Netherlands than the person sitting next to him in the Paris office, for instance, belonging to the smart industries team. You see here what the value creation scope is of these four platforms. The main reason why we have chosen to be organized in this way is that over the last couple of years, and this is in fact already taking place as of 2012, 2013, we see that specialization really becomes the key in our business in order to create value. In the past, maybe private equity was a bit more financially driven and more driven by putting in place a good capital structure and financial structure. This has become a commodity and today it really is about creating value. It is about thinking with the entrepreneur of the portfolio company on how we can further grow his company, what the best strategy is to do so, how we can further grow his company or her company with M&A, with further acquisitions. So there is a wide range of value creation strategies that is based on a thorough knowledge and insights in the different industries we invested. So already with that approach, we offer a kind of diversification with regards to the composition of our portfolio.
Maybe to give some examples on that approach, I want to go to the next slide just to illustrate a bit more on how this is made concrete. And here I present you some new investments we did over the last year. I will quickly go into what these companies do, just to show how we look at investment selection in the portfolio composition. So for the consumer area, we have invested in back in March of this year in a company called Sofa Tutor in Germany. Sofa Tutor is the leading digital education platform in Germany. We all have seen that throughout COVID, digitalization in our economy but certainly also in our education activities has seen a very rapid development. We don't think that this will stop; on the contrary it will only further accelerate. And therefore we think it is very useful and interesting to invest in a company that is already the leader in that area in the German market. For our health and care platform on the top right side, we have invested recently in a company called Biolam. Biolam is a group of medical laboratories in the northwest of France. Medical laboratories, of course, needless to say that we have seen the use of that over the last 18 months, but next to that, it's not only corona related but it is also a growing trend towards more medical diagnostics and the need for that is only increasing. This investment is really a buy-and-build investment, so you really want to build a network of medical laboratories in that area. Since our investments, we have done already five add-on acquisitions in the last 12 months, so really a rapidly growing company. For smart industries, I want to share with you our investment in Televic. Televic is a Belgian company that is very innovative in the development of communication solutions, communication products for a wide range of activities, for instance in public transport but also in healthcare, but also in conference systems. They are at the forefront of technical innovation and also they have a very international scope. I just want to share with you that the whole conference system of the United Nations for instance is provided by the company Televic. Rapidly growing as well, and a new investment in our smart industries platform. And then just to share with you also how we look at value creation from a sustainable cities perspective, we have been investing in Verclair. Verclair is a Dutch company that builds out networks for utilities, both for energy utilities but also for telecom utilities, and they're supporting the trend towards electrification but also the trend to turn towards a stronger digital network that we need for a data-driven society. This is illustrative but just to share with you how we look at investment opportunities and how we think we can create value not only for the economy and for our shareholder but also for the society at large.
So these were just four examples. Here you see the total portfolio. Rest assured, I'm not going to describe the activities of all these companies. The only thing I want to say to you as a potential investor in the Gimv stock is that by buying the Gimv stock, you buy this portfolio. So you buy a large portfolio of all non-public companies or not yet public companies that have one common feature which is the growth potential. These are companies that are very diverse in their sectors, in their activities, but also very diverse in their phase of development. And maybe one illustration of that, next to the examples I already gave, is that we also have a portfolio today in place of about 10 biotech companies. This is, let's say, the activity where we invest in the earliest stage of development. And all of these companies have also strong development, strong potential for value creation. This is just coming back to the Televic I already explained this more in detail just a few minutes ago. So the only reason why we highlight this a bit more here is that we want to stress that also in Western Europe we can invest in industries, we can invest in companies that produce innovative systems and solutions, and there is really a way to do so. This is a rather large company, 130 million euros in turnover, about a thousand employees, with still strong growth potential. And Biolam already elaborated on that as well. As said, this is a buy-and-build approach for medical laboratories in France. Today, 15 laboratories in place with 150 employees, but this group will further grow strongly in the next couple of years.
So after having illustrated how we look at potential value, I would like to show you also the different levers that we identify at the moment that we select our investment opportunities. And you see here six areas of potential growth. One can be accelerating sales. It can really be that we detect a company or we see an investment opportunity in a company where the product is in place but where we still have to go for the best product-market combination and a more efficient and effective sales strategy can be there, the element to unlock the value. Another element can be the global anchoring, so that we look at the internationalization potential of these companies. They can be very strong in one specific area or one specific geography, but there can be a lot of international further value potential. Buy and build, I already mentioned that one through Biolam. That is an approach towards value creation that is applied more and more today. You buy one company that has the platform potential to become a leader in its sector, typically a sector that is characterized by a very high degree of proliferation, so they have a lot of different companies still active in that area, and where you through buy and build to acquisition again become a leader in the sector. From product innovation to go to market, this is typically for the companies that are a bit earlier in their development phase. The product is there, the strength of the product is proven by the fact that there are already some reference customers in place, but now it's all about go to market, it's about making the business model work to sell the products. Operational excellence can be another one where we can further improve the functioning of the company, where we can put processes in place, where we can put the reporting system in place, etc., in order to create value. And finally, there is also the strategic positioning. This typically comes more towards the end of our investment period where we want to highlight the strategic value, the strategic strength of a company within a certain sector in order to make it an attractive company for potential acquirers.
This is what we do, this is how we look at our portfolio. Maybe just some figures there on the bottom end of this slide. For instance, over the last year, within our portfolio of 57 portfolio companies, we have done 24 add-on acquisitions. This was next to seven new portfolio companies in which we invested throughout the last year. So it's a rather intensive activity. We had top-line growth as well as profitability growth over the last year, and this in contrast with the economy as a whole which shrank with about six to seven percent in that period. Our portfolio has seen both top line and profitability growth, and also through exits we have done, because you should know of course that we have also a rotation strategy with regards to our portfolio where we of course at a certain moment want to realize the value that is created through an exit, and over the last year there was 100 million euros of capital gains realized on companies we have sold, both to strategic investors as well as to new financial investors. How does this translate? This translates into a portfolio return as it is shown here over the last seven years. You should know that we have an internal target of a 15% cross portfolio return. Well, we have gone above that level for the last six out of seven years. Over this period, the year before the last year was of course impacted by the fact that we closed our annual accounts by at the end of March, and at the end of March last year in 2020, at that moment the capital markets were at their bottom with the impact of corona and the strong decline we have seen in capital markets. But this was more than compensated by the strong return we have realized over the last financial year with the 27% portfolio return, and over the last seven years we have an aggregate return of 18% on our portfolio, so clearly surpassing our target of 15.
Where does this portfolio return come from? And this is the next slide. As I said, we have a strong focus on growth, and this is also shown by the figures. This is an illustration of an analysis that we have done on the exits over the last five years. So the total investment cost of companies we have sold over the last five years was 316 million euros. The total proceeds of these exits is 1 billion 79 million euros. So you see that the exits that we have realized over the last five years generated a money multiple of 3x. So we have generated three times the money that we have invested. And we have also done an analysis of where this value creation came from, and here you see that 80% of that value creation was generated by growth. A much larger part came from multiple increase, so where the buyer was happy to pay a higher multiple versus the one we paid at the moment of our entry. And in fact, the deleveraging which is sometimes the characteristic that is applied to private equity value creation, for us as a company, it's not at all on average a source of value creation. So for us, sustainable value creation within private equity comes from growth. Hence the organization according to platforms, the specialization of our investment teams, and the approach we have to value creation with the six levers I shared with you. So this is really a proof of the success of our strategy with regards to our value creation.
That's the slide that concludes my explanation and my introduction on Gimv, because an element that I haven't touched upon yet is the dividend that we pay out. We on an annual basis pay out a rather stable dividend. Our policy is to keep the dividend stable and to increase it when it is possible in a sustainable way. Our dividend yield today is about 4.6%. So when looking at the evolution of the stock price, which is the red line here on this graph, you tend to underestimate the value creation that we do for our shareholders. And so if you add up the dividend to the value creation and even look at it with the dividend reinvested in the stock, you see a whole different picture. And if you see there on the graph the evolution of the last 10 years, you see that an investor in the share has more than doubled its investment, and over a period of 15 years, in fact, it's more than tripled its investment. So over the last 15 years, we have paid out 1 billion euros in dividends. If you compare that with the current portfolio of 1.2 billion euros, you could say that we have more or less distributed the total value towards our shareholders over a period of 15 years, and today we still have a new portfolio in place with about the same value. So it's about rotation, it's about value creation, it's about sharing that value creation with our shareholder, and at the same time also growing our own portfolio. As that we have a portfolio today of 1.2 billion euros, this is a record level for Gimv in its 40 years history, and we have the ambition and the intention to further grow it over the next couple of years. So with that, I would like to conclude my introduction to Gimv as an investment company, and I would like to hand over now for the Q&A.